These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15627813)

  • 21. Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study.
    Neuhaus AH; Koehler S; Opgen-Rhein C; Urbanek C; Hahn E; Dettling M
    J Psychiatr Res; 2007 Oct; 41(8):635-44. PubMed ID: 16908030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P300 reduction and prolongation with illness duration in schizophrenia.
    Mathalon DH; Ford JM; Rosenbloom M; Pfefferbaum A
    Biol Psychiatry; 2000 Mar; 47(5):413-27. PubMed ID: 10704953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased NoGo-anteriorisation in first-episode schizophrenia patients during Continuous Performance Test.
    Kleinlogel H; Strik W; Begré S
    Clin Neurophysiol; 2007 Dec; 118(12):2683-91. PubMed ID: 17910935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of reaction time in post-acute schizophrenia using electrophysiologic variables].
    Eichert V; Klosterkötter J
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):261-70. PubMed ID: 8765892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations among intelligence, executive function, and P300 event related potentials in schizophrenia.
    Dichter GS; van der Stelt O; Boch JL; Belger A
    J Nerv Ment Dis; 2006 Mar; 194(3):179-87. PubMed ID: 16534435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single trial analysis of event related potentials: a comparison between schizophrenics and depressives.
    Röschke J; Wagner P; Mann K; Fell J; Grözinger M; Frank C
    Biol Psychiatry; 1996 Nov; 40(9):844-52. PubMed ID: 8896770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of facial expression and visual P300 in schizophrenic patients: differences between paranoid type patients and non-paranoid patients.
    Ueno T; Morita K; Shoji Y; Yamamoto M; Yamamoto H; Maeda H
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):585-92. PubMed ID: 15601381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in P300 latency and amplitude in schizophrenic patients and healthy controls during the examination.
    Louzã MR; Maurer K; Neuhauser B
    Electromyogr Clin Neurophysiol; 1992 Dec; 32(12):603-10. PubMed ID: 1493774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P300 energy loss in aging and Alzheimer's disease.
    Ashford JW; Coburn KL; Rose TL; Bayley PJ
    J Alzheimers Dis; 2011; 26 Suppl 3():229-38. PubMed ID: 21971463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
    Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms.
    Preuss UW; Zetzsche T; Pogarell O; Mulert C; Frodl T; Müller D; Schmidt G; Born C; Reiser M; Möller HJ; Hegerl U; Meisenzahl EM
    Psychiatry Res; 2010 Aug; 183(2):133-9. PubMed ID: 20630714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition.
    Chun J; Karam ZN; Marzinzik F; Kamali M; O'Donnell L; Tso IF; Manschreck TC; McInnis M; Deldin PJ
    Schizophr Res; 2013 Dec; 151(1-3):175-84. PubMed ID: 24210871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P300 event-related potentials and cognitive function in social phobia.
    Sachs G; Anderer P; Margreiter N; Semlitsch H; Saletu B; Katschnig H
    Psychiatry Res; 2004 Sep; 131(3):249-61. PubMed ID: 15465294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JH; van der Meer JN; Bour LJ; de Haan L; Linszen DH
    Biol Psychiatry; 2010 Oct; 68(7):642-8. PubMed ID: 20627236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies.
    Bestelmeyer PE; Phillips LH; Crombie C; Benson P; St Clair D
    Psychiatry Res; 2009 Oct; 169(3):212-9. PubMed ID: 19748132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
    Mori K; Morita K; Shoji Y; Matsuoka T; Fujiki R; Uchimura N
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):261-9. PubMed ID: 22624730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P300 amplitude over temporal regions in schizophrenia.
    Iwanami A; Kato N; Kasai K; Kamio S; Furukawa S; Fukuda M; Nakagome K; Araki T; Okajima Y; Isono H; Kamijima K
    Eur Arch Psychiatry Clin Neurosci; 2002 Feb; 252(1):1-7. PubMed ID: 12056575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and neuropsychological correlates of the P300 in schizophrenia.
    Nieman DH; Koelman JH; Linszen DH; Bour LJ; Dingemans PM; Ongerboer de Visser BW
    Schizophr Res; 2002 May; 55(1-2):105-13. PubMed ID: 11955970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.
    Coburn KL; Shillcutt SD; Tucker KA; Estes KM; Brin FB; Merai P; Moore NC
    Biol Psychiatry; 1998 Sep; 44(6):466-74. PubMed ID: 9777178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P300 and neuropsychological tests as measures of aging: scalp topography and cognitive changes.
    Fjell AM; Walhovd KB
    Brain Topogr; 2001; 14(1):25-40. PubMed ID: 11599530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.